Neurology® Podcast

The Neurology Podcast provides practical information for neurologists and clinicians to practice the best possible medicine for patients. Examining methods and findings in peer-reviewed journals, the show provides insights that impact clinical practice and patient care. Each week listeners may earn CME credits by completing online quizzes at neurology.org. From the journal Neurology and the American Academy of Neurology, providing education and expert analysis since 2007.

https://www.neurology.org/podcast

Eine durchschnittliche Folge dieses Podcasts dauert 25m. Bisher sind 5534 Folge(n) erschienen. .

Gesamtlänge aller Episoden: 104 days 3 hours 43 minutes

subscribe
share





Symptoms and Incidence of RCVS; Optimizing Stroke Prevention in Atrial Fibrillation


Symptoms and Incidence of RCVS; Optimizing Stroke Prevention in Atrial Fibrillation


share







   25m
 
 

Illness in Overseas U.S. Embassies Employees; Afferent Baroreflex Failure


Illness in Overseas U.S. Embassies Employees; Afferent Baroreflex Failure


share







   29m
 
 

Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's


Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's


share







   31m
 
 

Management of Neurologic Conditions in Pregnancy (Neurology Recall July 2021)


Management of Neurologic Conditions in Pregnancy (Neurology Recall July 2021)


share







   1h19m
 
 

Neurology, Journal, Podcast


SPECIAL REPORT: A Discussion with Mary Post (Part 2)


share







 2021-06-28  12m
 
 

SPECIAL REPORT on Aducanumab Approval: A Pulitzer Prize-winning Journalist's Perspective


SPECIAL REPORT on Aducanumab Approval: A Pulitzer Prize-winning Journalist's Perspective


share







 2021-06-24  31m
 
 

SPECIAL REPORT: A Discussion With Mary Post (Part 1)


SPECIAL REPORT: A Discussion With Mary Post (Part 1)


share







 2021-06-21  11m
 
 

SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists


SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists


share







 2021-06-19  11m
 
 

SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact


SPECIAL REPORT on Aducanumab Approval: Steve Pearson of ICER Discusses the Economic and Clinical Impact


share







 2021-06-17  30m
 
 

A Discussion With Dr. John Quinlan; Readmission Risk for RCVS


A Discussion With Dr. John Quinlan; Readmission Risk for RCVS


share







 2021-06-14  31m